These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1712273)

  • 1. Cilazapril in congestive heart failure. A pilot study.
    Kiowski W; Drexler H; Meinertz T; Zuber M; Ritz R; Burkart F; Just H
    Drugs; 1991; 41 Suppl 1():54-61. PubMed ID: 1712273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
    Kiowski W; Zuber M; Elsasser S; Erne P; Pfisterer M; Burkart F
    Am Heart J; 1991 Nov; 122(5):1382-8. PubMed ID: 1683143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive changes in the acute haemodynamic effects of cilazapril during chronic treatment. Comparison with long-term clinical effect.
    Larsen J; Sykulski R; Jensen G; Dössegger L; Trimarco B; Moccetti T; Glogar D; Schelling A; Bosma AH
    Eur J Clin Pharmacol; 1996; 50(6):433-41. PubMed ID: 8858268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure therapy with cilazapril: an overview.
    Dössegger L; Nielsen T; Preston C; Arabatzis N
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S38-41. PubMed ID: 7700063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of handgrip stress test on hemodynamic parameters before and after cilazapril treatment in patients with heart failure.
    Tavli T; Göçer H
    Anadolu Kardiyol Derg; 2003 Mar; 3(1):38-42. PubMed ID: 12626309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
    Bulpitt CJ; Fletcher AE; Dössegger L; Neiss A; Nielsen T; Viergutz S
    Heart; 1998 Jun; 79(6):593-8. PubMed ID: 10078088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
    Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I; Kassel P; Duck HG; Fiehring H; Morgan P; Schmidt PK; Höfs T; Nehmiz G
    Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
    Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial and steady state pharmacokinetics of cilazapril in congestive cardiac failure.
    Wiseman MN; Elstob JE; Francis RJ; Brown AN; Rajaguru S; Steiner J; Dymond DS
    J Pharm Pharmacol; 1991 Jun; 43(6):406-10. PubMed ID: 1681053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ischemic effects of cilazapril in patients with both hypertension and angina pectoris. Preliminary report of a pilot study.
    Schneeweiss A; Marmor AT; Rettig-Stürmer G
    Cardiology; 1991; 79(1):46-8. PubMed ID: 1838032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new angiotensin converting enzyme inhibitor, cilazapril, on circulating atrial natriuretic factor during exercise in patients with essential hypertension.
    Kohno M; Yasunari K; Murakawa K; Yokokawa K; Horio T; Kurihara N; Takeda T
    J Hypertens Suppl; 1989 Dec; 7(6):S298-9. PubMed ID: 2534417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibition with cilazapril improves myocardial perfusion to the ischemic regions during exercise: a pilot study.
    Gasic S; Dudczak R; Korn A; Kleinbloesem C
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):227-32. PubMed ID: 1689417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension.
    Belz GG; Breithaupt K; Erb K; Kleinbloesem CH; Wolf GK
    J Hypertens; 1989 Oct; 7(10):817-24. PubMed ID: 2531184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial.
    Dössegger L; Aldor E; Baird MG; Braun S; Cleland JG; Donaldson R; Jansen LJ; Joy MD; Marin-Neto JA; Nogueira E
    Eur Heart J; 1993 Jul; 14 Suppl C():18-23. PubMed ID: 8365423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.